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Chapter One
Introduction
Pain as a multidimensional experience
After observation of patients with atypical facial pain, G. L. Engel concluded in 1951 that
no pain exists without involvement of central nervous structures and in spite of having a
physiological basis, pain is primarily a psychological phenomenon. These thoughts were further
developed and proposed in the “Gate Control Theory” in 1965 by Melzack and Wall and
expanded in 1968 by Melzack and Casey. Thereby a theory was presented that showed the
parallel processing and integration of physiologic and “psychologic” elements in pain. In this
way previous biomedical–mechanistic thought processes were incorporated into a bio-psychosocial model, and the importance of psychosocial factors in the field of pain was established.
The “Gate Control Theory” not only proposed a model for pain modulation at the dorsal
horn level, but it also stated that ascending nociceptive information is transmitted via two main
central pathways. One is the neospinothalamic tract to the ventrobasal thalamus and the
somatosensory cortex, which is thought to represent the neurological basis for the sensorydiscriminative pain dimension. The other is the “paramedian” pathway to the medial and intralaminar thalamus, the limbic system and the frontal lobe via and with connections to the reticular
formation. This second pathway is proposed to be responsible for pain-related motivational
drive, behavioral arousal and unpleasant affect (Melzack & Casey, 1968).
In addition to sensory/discriminative and emotional/motivational factors in the processing
of nociception, other elements also play an important role in pain perception and need to be
taken into consideration. These are cognitive/evaluative processes of higher brain centers,
utilizing memorized information created by previous experiences involving painful events and
their consequences, as well as genetically determined thinking and reaction patterns. The
interaction between the sensory/discriminative, emotional/motivational and cognitive/evaluative
systems leads to the resultant pain behavior. Pain behavior is the objectively observable,
individual, non-verbal and verbal “external” expression of the subjective pain experience and
accompanying suffering. Most of the activity in the effector organs involved in pain behavior is
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mediated by physiological stress responses characterized by increased activity in the motor,
endocrine, autonomic, immune and opioid systems.
Studies using functional MRI (Coghill et al, 1994) have suggested that the
neuroanatomical substrates for the sensory-discriminative component of pain are the primary and
secondary somatosensory cortices of the parietal lobe. The affective quality of pain involves
primarily the anterior insular cortex of the frontal lobe. The affective-motivational aspects of
pain are assigned to the anterior cingulate cortex, also of the frontal lobe. These findings in
humans support the previous theories of the central pain pathways that were predominantly
based on behavioral and neurophysiological observations in animals. They also confirm the
necessity of considering both mind and body when dealing with pain.
Melzack integrated the original Gate Control concepts into his “Neuromatrix Theory” of
pain (1989, 1990, 1992, & 1999) and proposed that besides aiming at restoring homeostasis, the
previously discussed stress responses to nociception can produce tissue changes that
subsequently act as additional inputs to the neuromatrix. Other inputs are considered to be
sensory, emotional and cognitive stimuli from additional brain areas, as well as intrinsic neural
inhibitory modulation. The neuromatrix is postulated to be a neuronal network consisting of
somatosensory, thalamocortical and limbic structures producing “neurosignature” output patterns
that activate perceptual, homeostatic and behavioral programs. A “neurosignature” output pattern
is thought to be the individualized neuronal activation of these effector systems, based on genetic
neuronal control and a multiplicity of other factors as mentioned above. It is important to
acknowledge that according to the “Neuromatrix Theory”, these effector systems can be
triggered independently of sensory input. Nevertheless, one can see that pain is proposed to be a
multidimensional construct with both sensory and affective components, which also was stated
by IASP in 1979.
For comprehension and didactic reasons it is tempting to maintain the separation between
physiology and psychology in pain, although the reality may be even more intricate than one
likes to believe. Sullivan (2001) for example, described the complexity involved in creating the
pain experience through what he claims to be a product of many interpretational processes. He
argues against the mind – body dualism of pain and states “There is no center of the brain where
the pain observer sits; there is no point within the nervous system where interpretation of pain
experience begins. There is no location within the organism where nociception becomes pain”
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(page 152). So, Sullivan actually goes a step further and questions if our knowledge really is
good enough to neuroanatomically define pain or if individual pain experiences can be defined in
terms of neuroanatomy at all.
Emotions and pain
General affective/emotional aspects of pain were postulated by Melzack to be potential
inputs to the neuromatrix. Based on nociception and/or its causative/related events, these
emotional aspects take part in the perceptual creation of the pain experience. Additionally,
emotions are potentially found on the “output-side” as well. They can represent responses to the
pain experience itself and – especially when pain persists – responses to possible consequences
of the pain. Subsequently they can also serve as secondary inputs to the neuromatrix. Associated
emotions experienced by chronic pain patients commonly include depression and anxiety
(Gaskin et al., 1992).
Depression has been defined as “A temporary mental state or chronic mental disorder
characterized by feelings of sadness, loneliness, despair, low self-esteem, and self-reproach;
accompanying signs include psychomotor retardation or less frequently agitation, withdrawal
from social contact, and vegetative states such as loss of appetite and insomnia” (Stedman’s
Medical Dictionary, 27th edition). Banks & Kerns (1996) estimated a prevalence of 30-54% of
depression in a clinic-based chronic pain population. This high prevalence underlies the major
role of depression in chronic pain and suggests that depressive symptoms not only would
dramatically change the behavior, especially with pain chronicity, but also quantitatively change
the emotional input to higher centers in chronic pain patients.
The same influence seems also to hold true for other negative emotions, for example
anxiety. Stedman’s Medical Dictionary (27th edition) defines Anxiety as “Fear or apprehension
or dread of impending danger and accompanied by restlessness, tension, tachycardia, and
dyspnea unattached to a clearly identifiable stimulus”. In 1996, McCracken et al. reported that
anxiety accounted for 16-54% of the variance in pain report, disability, and pain-related behavior
among persons with chronic pain. Again, these numbers confirm the quantitative importance of
negative emotions among chronic pain patients, and support the value of the biopsychosocial
model for pain.
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Historically the chronic pain experience is known to be accompanied by strong negative
emotions. It is therefore not surprising that depression, anxiety and anger correlate strongly with
each other and also form a single affective distress factor when employed in structural equation
modeling studies with chronic pain (Brown et al., 1996). There are other studies, however, that
suggest each of these constructs contribute unique variance to the prediction of pain-related
negative affect (Robinson & Riley in “Psychosocial Factors in Pain”, Gatchel & Turk ed, 1999).
These findings suggest that the separate use of these constructs is justified.
The link between emotional distress and physical symptoms
Mechanisms linking emotional distress with physical symptoms include autonomic
arousal, vigilance and misinterpretation (Sullivan & Katon, 1993) and somatic amplification
(Barsky & Klerman, 1983). Somatic amplification is defined as an increased awareness of bodily
sensations. Barsky et al. (1988) proposed that physiological events related to chronic pain could
generate this sensitizing effect as a consequence of prolonged exposure to this stressor. The
relationship can theoretically exist in the following ways: a) Negative emotion increases somatic
sensitivity; b) Negative emotion causes pain/part of pain; c) Experience of chronic pain causes
negative emotion and d) Negative emotion and pain are concomitant constructs, because of
similar biological foundations (Brown, 1990; Banks and Kerns, 1996; Fishbain et al., 1997).
These potential relationships are depicted in Figure 1.
Mediators between negative emotions and chronic pain
Theoretically, on an individual basis any one of the alternatives in Figure 1, as well as
various combinations could be possible. Somatic amplification could of course also be preceding
and leading to dysphoria. Cohen and Rodriguez (1995) underscored the bi-directional nature of
biological, behavioral, cognitive and social pathways in the development and maintenance of
affective and physical disorders. The complexity of these interactions implies that the
relationship between pain and emotional factors is not of a direct nature, but seems to be
mediated by other variables. Among several constructs suggested being responsible for the
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comorbidity of pain and negative emotions are Somatization and Dysfunctional Cognitive
Processes (Robinson & Riley in “Psychosocial Factors in Pain” Gatchel & Turk ed, 1999).
Somatization has been defined in several ways. One definition is: “The process by which
psychiatric or psychological factors present as physical symptoms” (Dickens & Creed in
“Postgraduate Psychiatry”, Appleby et al. ed, 2001). This implies the experience of pain without
actual nociception or the amplification of the pain-experience due to accompanying negative
emotions. Cognition is defined by Stedman’s dictionary (27th edition) as “a generic term
embracing the mental activities associated with thinking, learning and memory”. It can be seen
that cognition is a very broad term encompassing different kinds of mental processes including
logic and illogic ways of creating concepts, solving problems, making decisions and forming
judgments. The role of cognition as a mediator between chronic pain and negative emotions is
based on the assumption that thoughts intervene between events and emotional reactions. These
thoughts could be based on previous experiences and/or related to the actual event.
Catastrophizing represents one such intervening mental process, which seems to be of
importance in chronic pain. It is defined as “a cognitive process characterized by negative
expectations about future outcomes and lack of confidence” (Sullivan & D’Eon, 1990).
Cognitive models of depression view negative cognition as distinct from, but related to
symptoms of depression, underpinning the fact that they are two distinct constructs (Beck, 1976).
The measurement of constructs like Somatization and Negative Cognition can be performed
through the administration of psychometric tests. A Somatization or Cognition score achieved on
a standardized psychometric test represents a numerical expression of the quantity and quality of
the reported symptoms in question. The severity of the reported symptoms can be derived by
comparing the score with known scores for a demographically matched group. The distance from
the “norm-value” is usually expressed in standard deviations.
Role of somatic factors
Over time various definitions of somatization have been suggested, and Wilson et al.
(1994) feel this has led to confusion about use of the term in any particular context. They
underscore the necessity of distinguishing somatization as a psychiatric disorder from
somatization as a dimension of personal functioning. For example Dworkin (in Gatchel and Turk
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ed, 1999) defines somatization as “a dimension of personal functioning characterized by the
tendency to report distress arising from multiple, non-specific physical symptoms accompanied
by increased healthcare visits”. Somatoform psychiatric disorder is defined (in DSM IV, 1994)
as “the presence of a minimum of eight physical symptoms, distributed over multiple organ
systems and not explained by a diagnosable medical condition”. So, although the basic definition
of somatization is the same, the difference between somatization as a personal dimension and as
a psychiatric disorder is dependent upon the quantitative and qualitative expressions of the
somatic symptoms.
Somatization as part of a standardized, psychometric screening instrument reflects nonspecific physical symptoms that are perceived as distressful (Escobar 1987, Simon 1993).
Derogatis (1977) defines the Somatization subscale of the Symptom Checklist-90-Revised (SCL90-R) as a dimension reflecting distress arising from perceptions of bodily dysfunction. He
included symptoms from autonomically controlled systems (cardiovascular, respiratory and
gastrointestinal), headaches, muscle pain and somatic equivalents of anxiety. He claims that
these symptoms have a high prevalence in functional disorders, but may of course also reflect
physical disease itself.
Grunau et al. (1994) searched for precursors of somatization by comparing extremely low
birthweight premature infants (representing children exposed to early distress and pain) with fullterm ones. They concluded that the etiology of somatization is a multidimensional problem and
found non-optimal parenting as a contributing factor to development of inappropriate coping
strategies with childhood pain. Noyes et al. (2001) reported that certain personality disorders,
especially the obsessive-compulsive type and also self-defeating, depressive and negativistic
personality traits contribute to somatization. Craig (1990) feels that social interactions and not
intrinsic properties are decisive for the development of somatization. Dworkin (1994) also
pointed out the contributing role of cultural factors and of medical institutions that focus
exclusively on physical symptoms. After reviewing the literature relating to gender differences in
somatization, Wool and Barsky (1994) stated that women report more functional symptoms than
men do. As the literature contained many confounding variables and flaws, the authors did not
consider this conclusion fully decisive. Bridges (1991) found a great similarity between primary
care patients with somatic symptoms of distress and patients presenting with psychological
symptoms. He stated that some evidence suggest “somatizers” to be less depressed and socially
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distressed compared to “psychologizers”, but in a patient population this seems to be even less
true.
Somatization scores seem to be elevated in chronic pain samples and positively correlated
to the number of pain complaints (Walker et al., 1988; Dworkin, 1990). Perceived disability also
increases linearly with increasing number of reported symptoms (Katon et al., 1991). The
relationship between psychological distress and somatization has been reported in various ways.
Some authors report that such distress, especially involving depression and anxiety, seems to be
a primary determinant of somatic amplification i.e. non-painful experiences are interpreted in
terms of pain (Simon & vonKorff, 1991; Dworkin, 1994; Kosturek et al., 1998). Other authors
can only confirm a co-existence between depression and somatic symptoms and between
depressive disorders and pain complaints (Smith, 1992). Hiller et al. (2000) could not verify a
general distinction between a “pure” pain disorder and a pain condition also involving multiple
somatoform symptoms. They found equal amounts of general depression, dysfunctional attitudes
and use of pain coping strategies in the two populations, but the multiple somatization group
revealed higher degrees of affective and sensoric pain sensations and more pain related
disabilities than did the “pure” pain group.
The Somatization construct has not only been used to predict properties concerning
current patient conditions, but also prospective predictive properties of this construct have been
reported. For example, it was shown in a prospective study of TMD-patients that the initial
general somatic complaints were the best predictors of TMD pain at 2-year follow-up (Vassend
et al., 1995), that somatization together with pain intensity and severity were the major predictors
for the transition from acute to chronic TMD problems (Garofalo et al., 1998) and that
somatization was a significant predictor of poorer treatment response in TMD patients
(McCreary et al., 1992).
Role of cognitive factors
Several studies have examined the role of cognitive factors in the mediation between pain
and psychological distress. A direct link between pain and depression could not be confirmed in
a study by Rudy et al. (1988), but measures of perceived life interference and self-control were
found to be significant intervening variables between pain and depression. Smith et al. (1994)
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found that both depressed pain patients and depressed non-patients reported more cognitive
distortion than their non-depressed counterparts. Sprock et al. (1983) compared depressed and
non-depressed pain patients and normals and detected a significant positive correlation between
degree of impairment in cognitive function and severity of depression. This finding was
independent of pain report. In a study by Ingram et al. (1990), depressed chronic pain patients
exhibited significantly more negative automatic thoughts than non-depressed pain patients and
healthy controls. A recent study by Severeijns et al. (2001) found that catastrophizing was a
potent predictor of pain intensity, disability and psychological distress. They reported no
difference between chronic low back pain patients, patients with chronic musculoskeletal pain
other than lower back and for pain patients excluding the previous groups. Jensen (1999)
confirmed previous findings that patient beliefs about their chronic pain influence and is
associated with their behavioral and psychological functioning. All these findings suggest that
cognitive factors, particularly related to dysfunctional thought patterns, may lead to the
development of dysphoria among chronic pain patients.
Ciccone (1984) concluded that behavioral interventions in chronic pain are effective
because they facilitate the development of new thinking skills that explicitly challenge the
cognitive causes of pain. Tota-Faucette et al. (1993) examined factors responsible for the
outcome of multidisciplinary management of chronic pain inpatients. They found that increases
in pain control and rational thinking were related to decreases in depression and anxiety, pain
report and activity discomfort. They also studied the role of negative social cognitions, which
include thoughts of being alone with ones pain, lack of social support and that no one else cares
about ones suffering. It was found that when negative social cognitions decreased, so did
depression at post treatment. It can be concluded that a change from irrational to rational
thinking can lead to an improvement in general well-being, based on favorable changes in
emotions, pain perception and/or activity level.
DeGood & Kiernan (1996) studied the perception of fault in patients with chronic pain.
They compared a group that blamed someone else (e.g. employer or other driver) for their pain
with a group not blaming anyone. The fault group reported greater concurrent mood distress and
behavioral disturbance, as well as poorer response to past treatments and lower expectations of
future benefits compared to the non-fault group. The authors claim that their data support the
perception or attribution of blame as an under-recognized cognitive correlate of pain behavior,
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mood disturbance and poor response to treatment. It seems reasonable to believe that strong
emotions, feelings of anger and belief about a need for revenge and justice can give rise to the
distress in patients holding someone else responsible for their pain, especially when the blamed
party denies such responsibility.
Ethnic/cultural elements also seem to influence cognitive mediation in chronic pain. After
studying chronic pain populations in New England and in Puerto Rico, Bates and Rankin-Hill
(1994) found that ethnic/cultural background and locus of control style were the factors most
often associated with statistically significant differences in pain intensity, pain responses and
adaptation to the chronic pain experience. For the majority of the studied groups, ethnic/cultural
identity was a predictor of locus of control style. The data also suggest that locus of control is not
necessarily a permanent, unchanging cognitive characteristic, but may be altered by the chronic
pain experience, behavioral interventions, and ethnic/cultural factors. Due to not only significant
inter- but also intra-ethnic/cultural-group differences, the authors stress the need to assess each
patient individually within the context of her/his total psychosocial and biocultural environment.
Some data exist on the effect of pain on cognitive processing. One example is Grigsby et
al. (1995) who compared chronic pain patients with persons who had sustained moderate head
trauma. The mean scores for both groups were lower than the normative mean on different
information processing and motor tests. No inter-group differences were found on motor
measures, but the pain patients performed more poorly than the head trauma group on the
information processing tests. The results suggest that pain may disrupt cognitive performances,
which depend on intact speed and capacity for information processing. One can clearly see that
data exist in support of complex, bi-directional relationships concerning the mediators between
pain and emotions.
Depression and anxiety as compound constructs
As discussed earlier, depression and anxiety can be viewed as separate constructs, but
there have been questions as to if each of them represent a uniform construct. Considering
depression, the debate originated due to the presence of cognitive and somatic items on the
Depression scale and therefore a contribution of both cognitive and somatic symptoms to the
Depression score (Rodin & Voshart, 1986; Buckelew et al. 1986; Geisser et al., 1997).
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Concerning anxiety, the presence of physiological symptoms on most assessment scales used in
pain patients have led to doubt of the uniformity of the construct (McCracken et al., 1992, 1996).
Additionally, the complex nature of anxiety can also be seen from its common definition as
consisting of components involving cognitive, physiological and behavioral/motor elements
(Lang, 1968). Therefore, depression and anxiety can both be regarded as compound constructs
with somatic and cognitive elements as important contributors.
Relative contributions of somatic and cognitive symptoms of anxiety and depression
Contrary to most studies, which have examined the role of either somatic or cognitive
factors, some researchers have developed a more differentiated view. They have reported on the
relative contributions of somatic and cognitive symptoms of anxiety and depression within the
same study population, with and without physical symptoms and pain. In the following, a review
of these studies will be presented.
Based on a model proposing a multidimensional nature of anxiety, Schwartz et al (1978)
constructed the Cognitive-Somatic Anxiety Questionnaire (CSAQ), which is a trait anxiety
inventory consisting of 14 items, seven cognitive and seven somatic items. The degree to which
the participants typically experience the symptoms described by the different items when they
are feeling anxious is to be rated between 1 and 5, where “1” represents “not at all” and “5”
represents “very much so”. The CSAQ was administered to 44 subjects (predominantly females)
participating in a physical exercise class, representing a somatically based activity. The CSAQ
was also administered to 33 subjects (with equal gender ratio) practicing cognitively based,
passive, daily meditation, representing a cognitively based activity. Although overall anxiety was
not significantly different between the exercisers and the meditators, the exercisers reported
significantly lower somatic than cognitive anxiety, while the meditators did not show any
significant difference between the two anxiety modes. The authors concluded that anxiety is not
an undifferentiated state. They proposed it is rather made up of patterns of specific
psychobiological processes, which would be important to assess and take into consideration
when dealing with affective disorders. They also question a unique generalized relaxation
response and suggest, based on their findings, that the consequences of different relaxation
techniques depend on the underlying biological system affected by the technique/procedure
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applied. This specific “technique-sensitive” effect would then be superimposed on a generalized
reduction in multiple physiological systems.
On the other hand, the authors were aware of a potential predispositional effect in that the
two study groups could possibly differ in their initial cognitive-somatic patterning. This study
was done in a cross-sectional manner on groups that had been performing either physical
exercise or meditation for approximately 6 months. It could therefore be argued that the study is
not providing any information about a possible “technique-sensitive” effect on or a change in the
symptom patterning over time for groups performing the two different activities. Such
differences would have to be studied in a longitudinal design.
Seven years after Schwartz’s study of cognitive-somatic symptom patterning in a nonpain population, DeGood et al. (1985) published a study involving chronic pain patients. They
administered the same questionnaire as Schwartz et al. (Cognitive-Somatic Anxiety
Questionnaire CSAQ, devised by Schwartz, Davidson and Goleman in 1978) to 100 chronic pain
patients and 100 college students. They found that the overall, global anxiety was lower in the
pain patients, but that the cognitive-somatic patterns of the responses differed between the two
groups. The pain patients reported significantly more somatic anxiety while the students
endorsed more cognitively oriented anxiety. The authors feel that the pain patients seem to fit the
description of “alexithymia” (Difficulty in recognizing and describing one’s emotions, defining
them in terms of somatic sensations or behavioral reactions). Unfortunately, the endorsements by
the two groups could be confounded by their initial differences on either the cognitive or the
somatic measures.
McCracken et al. (1998) studied a group of 210 adult, chronic pain patients and found
that collateral, non-specific, physical symptom complaints were common in this group. The
authors also discovered that physiological symptoms of pain-related anxiety and cognitive
symptoms of depression were significant predictors of physical symptoms. The somatic anxiety
component was the stronger predictor of the two. It is suggested that the results support a model
in which non-specific physical complaints arise directly due to distressing circumstances of the
pain experience and that emotional distress is more often a consequence than a cause of chronic
pain. Based on these findings it seems that somatic distress (pain-related) correlates more
strongly with physical complaints than general measures of distress do.
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Wilson et al (1994) examined how clinical findings related to affective, cognitive and
somatic symptom report. They combined information from the Somatization scale of the SCL90-R (Derogatis 1977, 1983) and from their own Emotional/Cognitive distress scale-construct
(based on removal of the somatic items from the SCL-90-R Anxiety and Depression scales) with
clinical findings from a chronic TMD muscle disorder patient population. They reported that
increased somatization and high pain intensity were strong predictors of widely dispersed pain
on muscle palpation. The patients with high somatization were also more likely to present a
painful placebo site on palpation. Affective and cognitive symptoms of psychological distress
were less likely to be related to report of clinically widespread pain. The authors suggested these
findings indicated that somatic and cognitive symptoms might relate differentially to
characteristics of pain report. They also suggested that the inclusion of somatic items on
psychometric scales of emotional/affective distress could confound this differentiated
relationship.
Buckelew et al (1986) constructed a somatic and a cognitive subscale for depression and
anxiety based on the SCL-90-R (Derogatis 1977,1983). They assigned the somatic and cognitive
items on each of these scales to its own subscale and also assigned items to these subscales from
the group of seven additional items on the SCL-90-R. This resulted in the following four
subscales: Cognitive Anxiety, Somatic Anxiety, Cognitive Depression and Somatic Depression.
Besides using the existing scales for Anxiety, Depression and Somatization on the SCL-90-R,
they utilized the constructed subscales to compare the scores for chronic pain patients,
psychiatric inpatients and new hospital employees. Each scale and subscale has a score range
between zero and four, where four represents the highest endorsement. Each group contained 50
subjects, equally divided by gender, with an average age between 30 and 38 years old. The
chronic pain group consisted of referred patients to the University of Virginia’s outpatient Pain
Management Center with average pain duration of 78.1 months. This group was a mixture of
patients with diverse primary pain locations: 68 % back, 14 % abdominal, 11 % headaches and 7
% other. The psychiatric patients were also representing several diagnostic groups, but 60 %
were diagnosed with an affective disorder. The chronic pain patients reported the highest scores
on somatization, as compared to the psychiatric inpatients and the hospital employees. The
psychiatric inpatients reported the highest scores on anxiety and depression as compared to the
chronic pain group and the hospital employees. Intra-group analysis showed equal levels of
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somatic and cognitive endorsement of anxiety and depression for the psychiatric inpatients and
the hospital employees. The chronic pain group showed higher somatic than cognitive subscores
for both anxiety and depression than the two other groups did. The authors suggested that the
cognitive-somatic symptom patterning for pain patients shown by DeGood et al in 1985 using
the special CSAQ construct of Schwartz, was detectable when using a standardized questionnaire
like the SCL-90-R. These findings led the authors to question the use of psychometric
instruments based on norm values from different populations in the evaluation of medical
patients. They suggested use of subscales to supplement the standard instruments, as equal test
scores, independent on quantitative endorsement, could reflect extremely different item
responses.
On analyzing an additional 150 pain patients, Buckelew et al. reported that they found a
subgroup of 30 patients with higher scores on cognitive than on somatic symptoms on at least
one of the anxiety and depression scales. They conveyed their impression that these patients
were more “psychologically minded”, had often consulted mental health professionals for
chronic pain or depression, took more personal responsibility and seemed more internally
focused with regard to their health problem and health care than other patients. The authors
advocated further research into the characteristics of this subset of pain patients endorsing
inversed cognitive-somatic symptom patterning compared to the majority of pain patients.
The present study
Previous studies on the relationship between cognitive-somatic symptom patterning and
pain, utilizing a standardized psychometric screening instrument (e.g. SCL-90-R) have only used
global expressions of pain like “TMD” or “chronic pain” (e.g. Buckelew’s chronic pain group
consisted of subjects with pain located to their back, abdomen, head or “other” areas) (Buckelew
et al., 1986) or have only looked at one subset of diagnoses (e.g. Wilson’s group consisted of
subjects with TMD-muscle pain) (Wilson et al., 1994). The studies have not used a specifically
defined non-pain control group and have not compared different (regional and widespread) pain
diagnoses and/or diagnostic subgroups. Further, somatic and cognitive patterning have not been
related to MPI (Multidimensional Pain Inventory) profile groups, representing different
expression of pain associated dysfunction.
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The present study will make use of specific diagnoses, diagnostic subgroups, a non-pain
control group and MPI profile groups. The objectives of the present study are to gain more
information concerning the relationships between cognitive-somatic symptom patterning,
anatomical distribution of pain and diagnostic subgroups of a regional pain. The first relationship
will be evaluated by comparing psychometric data from patients with a widespread pain
syndrome, patients with a regional, trigeminal pain and a non-pain control group. The second
relationship will be analyzed using psychometric and clinical data from diagnostic subgroups.
A theoretical model (based on Okeson’s masticatory muscle model, 1993) was developed
and is thought to represent a continuum starting with no pain, extending via “peripheral” regional
pain, “centrally mediated” regional pain to a widespread, systemic pain. A demographically
matched non-pain control group was expected to provide important data on existing, non-painrelated anxiety, depression and somatic/cognitive patterning. The regional pain syndrome was
represented by orofacial pain, which was subdivided into diagnostic subgroups of “muscle
disorder”, “intracapsular (TMJ) disorder” and “neuropathic pain disorder”. The orofacial pain
muscle disorder subgroup was further subdivided into two groups. The first was a group
consisting of the diagnostic entities Local Myalgia, Tendonitis and Muscular Co-contraction,
representing diagnoses with less central/potentially more peripheral involvement. The second
group comprised the diagnoses Myofascial Pain and Centrally Mediated Myalgia and was a
diagnostic group with potentially more central nervous system involvement than the first group.
The widespread/systemic pain was represented by fibromyalgia – a syndrome involving
qualitatively altered nociception and thought to be a manifestation of an altered central nervous
system processing of nociceptive stimuli (Bendtsen et al., 1997).
Aims and hypotheses
Female chronic Orofacial Pain patients and female Fibromyalgia patients from a tertiary
treatment center and a demographically matched Non-Pain control group completed the SCL-90R with the aims:
1) to compare among these different groups and among the diagnostic subgroups of the
Orofacial Pain patients (Muscle group, Intracapsular group, Neuropathic group) the mean
values for Somatization, Anxiety and Depression.
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It was hypothesized that Somatization, Anxiety and Depression scores for the Orofacial
Pain and Fibromyalgia groups would be higher than for the Non-Pain population. This was
based on the assumption that Somatization correlate positively with pain intensity level,
which was expected to be higher in the Neuropathic and Muscle subgroups and in the
Fibromyalgia group compared to the Non-Pain group and the Intracapsular subgroup. The
assumption was supported by the reports of elevated Somatization scores in chronic pain
samples and a positive correlation between Somatization scores and the number of pain
complaints (Walker et al., 1988 and Dworkin et al., 1990). As chronic pain patients often
experience anxiety and depression (Gaskin et al., 1992; Banks and Kerns, 1996; McCracken,
1996), it was also hypothesized that Anxiety and Depression scores would be higher for the
Orofacial Pain and Fibromyalgia groups than the Non-Pain group. It was predicted that the
Neuropathic, Local Muscle, Central Muscle and Fibromyalgia groups would reveal higher
Anxiety and Depression scores than the Intracapsular group, as the first four groups
potentially would involve greater life interference from pain than the Intracapsular group.
2) to compare among the groups and the subgroups the type and degree of cognitive-somatic
symptom patterning for the Anxiety and Depression subscales, after regrouping the somatic
and cognitive items of these scales.
Based on published data on cognitive-somatic patterning (Buckelew et al., 1986), it was
hypothesized that the Fibromyalgia and Orofacial Pain groups would reveal a higher somatic
than cognitive component on the Anxiety and Depression scales. The Non-Pain control group
was expected to reveal equal levels of cognitive and somatic scores on the Anxiety and
Depression scales. All the Orofacial Pain subgroups were expected to show a greater
expression of somatic than cognitive item responses on the Anxiety and Depression scales,
but the Intracapsular subgroup was expected to show a smaller difference between the
somatic and cognitive scores compared to the Neuropathic and Muscle subgroups. The
Fibromyalgia group was expected to reveal the greatest difference between the somatic and
the cognitive scores. These hypotheses were based on the assumptions from the previous
paragraph combined with an expected strong positive correlation between the somatic
subscale scores (on both the Anxiety and the Depression scales) and the Somatization score.
3) to compare among the different pain profile groups (“Dysfunctional”, “Interpersonally
Distressed” and “Adaptive Copers” based on the Multidimensional Pain Inventory (MPI)) the
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Somatization, Anxiety and Depression scores and to assess the relationship between
cognitive and somatic subscale endorsements for these groups.
As a higher pain intensity level was expected for the Neuropathic and Muscle groups
compared to the Intracapsular group and the pain level was thought to correlate with
Somatization, Anxiety and Depression, it was hypothesized that the Dysfunctional and
Interpersonally Distressed groups would reveal higher scores on Somatization, Anxiety and
Depression compared to the group of Adaptive Copers. This was also supported by the
finding that perceived disability increased linearly with increasing number of reported
symptoms (Katon et al., 1991). Based on the assumptions in paragraph number 2, higher
levels of somatic Anxiety and Depression among the Dysfunctional and Interpersonally
Distressed groups compared to the Adaptive Coper group were expected. The Adaptive
Copers were on the other hand thought to present either equal or higher levels of cognitive
Anxiety and Depression compared to the two other groups.
4) to compare all SCL-90-R scale scores between the following two subsets extracted from the
Orofacial Pain database:
a) Participants having a higher cognitive than somatic subscale score on the Anxiety and/or
Depression scales (i.e. participants revealing a positive difference when the somatic
subscale score is subtracted from the cognitive subscale score).
b) Participants having a higher somatic than cognitive subscale score on the Anxiety and/or
Depression scales (i.e. participants revealing a negative difference when the somatic
subscale score is subtracted from the cognitive subscale score).
The group endorsing cognitive items stronger than somatic items was, along with the
thoughts of Buckelew et al (1986) expected to deal with their pain more on a cognitive level
compared to the group endorsing somatic items stronger than cognitive ones. The latter group
was expected to reveal a higher level of psychopathology and therefore also higher scores on
the SCL-90-R scales compared to the other group.
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Figure 1: Theoretical unidirectional relationships between negative emotions and pain
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Pain

Chapter Two
Materials and Methods
Groups / Participants
The present study used data from three groups – two patient cohorts (groups B and C)
derived from university based tertiary treatment centers and one population-based, Non-Pain
control group (group A).
Group A / Non-Pain control group
Fifty-two female residents of the catchment area of the Kentucky Clinic in
Lexington/Kentucky with the same age distribution as the total Orofacial Pain study group were
recruited. The control population consisted of patients and accompanying persons recruited from
the waiting areas in the College of Dentistry and the Clinic for Adult Dentistry at the University
of Kentucky/Kentucky Clinic. When a person gave consent to participate after being informed
about the study, she was asked to complete a brief questionnaire and to record gender, month and
year of birth and place of residency. Additionally, psychometric data were collected. To be able
to participate, the participants had to be pain free at the time of data collection and not have had
any “chronic”, persistent or recurring pain during the preceding 6 months or for any period
during their lives lasting more than 3 months. Pain referred to pain in any location of the body.
The participants within each age cluster of the Non-Pain group were collected on a consecutive
basis. Eleven questionnaires had to be discarded due to incompleteness and additional
participants were recruited to achieve a total data set of 52 participants.
Group B / Orofacial Pain group
The participants that comprised this group had already been seen as part of a clinical
consultation in the Orofacial Pain Center at the College of Dentistry at the University of
Kentucky. For each of these participants clinical and psychometric data were available. Each
participant had completed consent to have her data used for research purposes. Most participants
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in the group had one or several diagnoses within the area of orofacial pain and these represented
mainly a regional, trigeminal, chronic pain. All participants had been assessed and diagnosed
according to the “Orofacial Pain - Guidelines for Assessment, Diagnosis, and Management”,
published by The American Academy of Orofacial Pain in 1996 (Ed. J.P.Okeson). The complete
Orofacial Pain database as of May 2002 consisted of 2,404 subjects and was used as the basis for
selection and grouping of participants. The age range was 6 to 90 years with the majority of the
subjects being 20 to 50 years old. 85% of the subjects were females and 15% males. The
majority of the subjects were living in Kentucky at the time of examination. Participants were
selected from the total database and divided into three groups for further analyses as follows: a)
all female participants with a primary diagnosis of temporomandibular joint (TMJ) intracapsular
disorder, b) all female participants with a primary diagnosis of neuropathic pain and c) all female
participants with a primary diagnosis of muscle disorder. For all three groups, participants with
secondary and/or tertiary diagnoses deviating from the primary one were excluded. The number
of participants in the different subgroups can be found in Table 1. The Neuropathic Pain group
was further subdivided in two groups: Episodic and continuous neuropathic pain. The Muscle
Pain group was also subdivided into two categories:
I)

Group with potentially less central nervous system involvement, represented by the
diagnoses Local Myalgia, Tendonitis and Muscular Co-Contraction.

II)

Group with potentially more extensive central nervous system involvement, represented
by the diagnoses Myofascial Pain and Centrally Mediated Myalgia.

Group C / Fibromyalgia group
The data from this group had already been collected as part of an extensive study on
fibromyalgia carried out in the Department for Physical Medicine and Rehabilitation at the
Medical Center of the University of Kentucky. All participants had been diagnosed with
fibromyalgia according to the 1990 American College of Rheumatology classification criteria. In
the present study, this group was included to represent a global / widespread, chronic pain
condition. The group consisted of 60 female participants, all residents of Kentucky. Ten
participants had to be excluded due to incomplete data, resulting in a final study group of 50
female participants. Forty-five (91.8%) of these participants reported jaw pain as part of their
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fibromyalgia complaint. The collected data consisted of demographic, clinical and psychometric
information.
Data for analyses
Demographic data
For all the 3 main groups, age was recorded. The distribution of the number of
participants for groups A, B and C as well as for the diagnostic subgroups of group B can be
found in Table 1, which also includes the corresponding mean ages.
Pain Ratings and Duration
Duration of the pain complaint was recorded in months, from onset of the pain complaint
until first evaluation / diagnosis in the Orofacial Pain Center for group B and from diagnosis
until participation in the previously mentioned study by the University of Kentucky Physical
Medicine Department for group C. Mean duration was in the range 66 months (Fibromyalgia) to
166 months (Local Muscle) and the median duration between 7 months (Central Muscle) and 36
months (Fibromyalgia) (Table 2).
Pain intensity was recorded through the patient’s pencil mark on a 100 mm VAS scale,
where the left demarcation represented “no pain” and the right demarcation represented “the
most imaginable pain”. The scale score was the distance from the “no pain” demarcation to the
patient’s mark, measured in millimeters and recorded as average (VASAVE) during the week
preceding the evaluation in the Orofacial Pain Center. VASAVE-scores were not available for
the Fibromyalgia group. Jensen et al. (1986) have reported acceptable construct validity of the
VAS scale, which also is in agreement with other pain intensity measurement methods. The
mean score for VASAVE was between 32 for the Intracapsular group and 59 for the Neuropathic
group (Table 2).
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Psychometric data
For all groups
The multidimensional psychological symptom inventory “Symptom Check List-90–
Revised” (SCL-90-R) (Derogatis et al 1976, 1983) was administered to all patients and also to
the participants in the non-pain control group. This inventory consists of 90 psychological
symptoms, each of which is rated on a scale 0 – 4, as to how much the specific symptom has
been bothering the participant during the preceding week. A score zero represents “not at all”,
one “a little bit”, two “moderately”, three “quite a bit” and four “extremely”. The 90 items are
divided into 9 scales and 7 additional items. The scales are Somatization, Obsessive-Compulsive,
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and
Psychotisism. Each scale score is obtained by dividing the sum of the item scores by the number
of items for the specific scale, resulting in scale raw-scores between 0 and 4. In this study the
raw-scores were used in the statistical computations and for group comparisons. Primarily the
Somatization, Anxiety and Depression scales of the SCL-90-R were utilized in the present study.
These scales are presented in Appendix B with their items listed. Satisfactory internal
consistency, test-retest reliability and construct validity of the SCL-90–R have been reported
(Derogatis, 1977). A copy of the SCL-90-R questionnaire is found in Appendix A.
To be able to quantify the somatic and cognitive aspects of the Anxiety and the
Depression scales separately, their scale items were regrouped and the 7 additional items of the
SCL-90-R were taken into account (according to Buckelew, 1986) as presented in Appendix C.
The score for each subscale was calculated in the same manner as for the scale raw-scores.
Reliability and validity data have not been published for these subscales. Chronbach’s Alpha was
calculated for each subscale for each main group as a measure of internal consistency reliability
in the present sample (Chronbach, 1951). An Alpha score of 0.7 or higher is considered
acceptable. In this study all the Alpha values, except for Cognitive Anxiety in the Non-Pain
group were higher than 0.7, suggesting acceptable internal consistency reliability for the four
constructed subscales for all main groups except the Cognitive Anxiety subscale in the Non-Pain
group (Table 3). Caution must be exerted when interpreting data involving the latter
constellation.
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The numeric values of the subscale scores themselves do not express anything per se and
we are only interested in the relationship between the corresponding somatic and cognitive
subscale scores for Anxiety and Depression within each group. To better express this relationship
and for easier statistical computations, the mean cognitive value was subtracted from the mean
somatic value. The resulting number being positive would mean that the somatic subscale score
was larger than the cognitive subscale score. A negative number meant a larger cognitive than
somatic subscale score.
For the non-pain control group
For clinical use, the SCL-90-R raw-scores are converted to t-scores, making the
comparison of an individual patient’s scores with the general non-psychiatric patient population
average (norm value) easier. A t-score of 50 represents the population average. In this study, the
t-scores were calculated for all SCL-90-R scales in the non-pain control group to be able to
compare this Kentucky based group to the norm values of the general population. The computed
t-scores for the non-pain group are listed in Table 4. From these scores and their accompanying
standard deviations it can easily be seen that there is no difference in SCL-90-R endorsements
between the Kentucky control group and the general non-psychiatric patient reference
population.
For the Orofacial pain group
The Multidimensional Pain Inventory (MPI) (Kerns, Turk & Rudy, 1985) was
administered to all patients seen in the Orofacial Pain Center. The MPI scores take on values
between 0 and 6, representing no and maximum positive endorsement respectively. Satisfactory
internal consistency and test-retest reliability as well as construct validity for the MPI have been
shown (Kerns et al., 1985). In this study, data from the MPI inventory were used to perform a
profile patterning of the pain patients into the groups “Adaptive Copers”, “Dysfunctional” and
“Interpersonally Distressed” according to Turk & Rudy, 1988. Adaptive Copers report high
levels of social support and activity, and low levels of pain and pain-interference with their lives.
Dysfunctional persons report high levels of pain-induced/-related psychological distress, paininterference with their lives, high perception of pain and low activity levels. Interpersonally
Distressed report poor social and domestic support in addition to a dysfunctional profile. The
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profile grouping was performed using a “Profile centroid distance test”, which is a chi-square
procedure testing the fit of a patient’s data with given profile-models.
Protection of anonymity
All data were released to and collected by the principal investigator in a way as not to
disclose personal identifiers of the participants. IRB approval from the University of Kentucky
was obtained and guidelines for the use of existing records were followed.
Statistical analyses
All analyses were conducted using the Statistical Package for the Social Sciences for
Windows (SPSS V-10). Histogram analyses revealed that most outcome variables for the
majority of the groups did not follow a normal distribution. Due to the fairly large number of
subjects per group and the reduction in power when using non-parametric tests, it was decided to
apply parametric statistics to the data analyses. A significance level of 0.05 was used for all
statistical tests. Independent sample t-tests were used for comparison of two independent groups.
Analyses of variance (ANOVA) were used for comparison of multiple groups. Analyses of covariance (ANCOVA) were applied to correct for the influence of potential confounding factors
like age, duration of pain (DURATION) and pain intensity level (VASAVE). For post hoc
analyses, Levene’s test was applied to test for homogeneity of error variances across groups.
Bonferroni’s test was utilized in the case of equal error variances. (This procedure accounts for
the multiple tests and adjusts the significance level accordingly). Games Howell’s test was used
in the case of unequal error variances. In this case, a Bonferroni-Holm procedure was then
applied to adjust the significance levels according to the number of tests performed. Paired t-tests
were used to test for equality between the somatic and the cognitive subscale scores of the
Anxiety and Depression scales.
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Average pain intensity
level
Mean (Std. error)
(100 mm VAS scale)

Median
32.12 (2.37)

25.49
59.33 (2.79)

18.00

45.34 (3.78)

12.00

56.46 (3.61)

7.50

36.00

Mean (Std. error) 125.48 (25.49) 73.75 (19.70) 166.60 (48.95) 99.33 (35.01) 66.24 (10.16)

Intracapsular

Groups / Subgroups
Neuropathic Local Muscle Central Muscle Fibromyalgia

Pain duration and average pain intensity level for the Orofacial Pain subgroups and Fibromyalgia group.

Duration of pain
(months)

Table 2:

Groups
Non-Pain
Fibromyalgia
Orofacial Pain
Intracapsular Neuropathic Local Muscle Central Muscle
52
134
88
46
49
50
39.62 (13.32)
45.44
(9.99)
41.48 (15.27)

Number- and age-distribution of participants among the groups/subgroups.

Number
Mean age (Std. dev.)

Table 1:
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Subscales
Somatic Anxiety Cognitive Depression Somatic Depression
0.81
0.91
0.77
0.80
0.92
0.79
0.81
0.93
0.71

Mean score
49.02
50.04
50.90
49.27
47.67
49.54
48.40
48.94
49.06

Std. deviation
8.90
9.55
9.43
9.35
8.51
9.47
6.77
9.41
7.70

T-scores for the SCL-90-R scales for the Non-Pain group.

Somatization
Obsessive-Compulsive
Interpers. Sensitivity
Depression
Anxiety
Hostility
Phobic Anxiety
Paranoid Ideation
Psychoticism

Table 4:

Cognitive Anxiety
0.31
0.86
0.75

Chronbach’s Alpha for the Anxiety and Depression subscales for the different diagnostic groups.

Non-Pain
Orofacial Pain
Fibromyalgia

Table 3:

Chapter Three
Results
Corrections for co-variants
In the group comparisons, the mean values were corrected for potential confounding covariants. Due to the different availability of these variants for the different groups, the following
adjustments were made: In comparison of the Non-Pain, Orofacial Pain and Fibromyalgia
groups, the mean values were corrected for age. In the comparison of the Orofacial Pain
subgroups with the Fibromyalgia group, the mean values were corrected for age and duration of
pain. Finally, in the comparison among the Orofacial Pain subgroups and the MPI profile groups,
the mean values were corrected for age, duration of pain and the pain intensity level.
Cognitive-somatic patterning for the Anxiety and Depression scales
The mean somatic subscale score was higher than the mean cognitive subscale score for
both the Anxiety and Depression scales in all groups and subgroups. Paired t-tests for intra-group
comparisons of the mean cognitive and somatic subscale scores yielded significant non-equality
of the mean subscores for both scales in all groups and subgroups (Table 5).
Analyses involving the Non-Pain group, Orofacial Pain group and Fibromyalgia group
Mean Somatization, Anxiety and Depression scores
The lowest mean values for the SCL-90-R Somatization, Anxiety and Depression scores
were found in the Non-Pain group and the highest values in the Fibromyalgia group (Table 6).
Analyses of variance revealed a significant group effect for Somatization (F(2,367) =
38.95 / p < 0.001), Anxiety (F(2,367) = 8.61 / p < 0.001) and Depression (F(2,367) = 14.40 / p <
0.001). Post hoc tests revealed significant group differences between all the mean values for the
Somatization, Anxiety and Depression scores.
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Cognitive-somatic patterning for the Anxiety and Depression scales
The numeric difference between the mean subscale scores for the Anxiety and the
Depression scales increased from the Non-Pain to the Orofacial Pain group and subsequently
from the Orofacial Pain to the Fibromyalgia group (Table 6).
Analyses of variance revealed a significant group effect for the numeric differences in
mean subscale scores for both the Anxiety (F(2,367) = 11.71 / p < 0.001) and the Depression
(F(2,367) = 6.48 / p < 0.001) scales. Post hoc tests for the mean subscale differences for the
Anxiety scale (CASA) revealed no significant difference between the Non-Pain and the
Orofacial Pain groups. Post hoc analysis for the mean subscale differences for the Depression
scale (CDSD) revealed significant difference between the Non-Pain and the Fibromyalgia
groups. The mean value for the Orofacial Pain group did not differ from the other two groups.
Summary
The lowest mean Somatization, Anxiety and Depression scores were found in the NonPain group and the highest mean scores in the Fibromyalgia group, with the Orofacial Pain group
taking on a middle value. The mean somatic subscale scores for Anxiety and Depression were
higher than the corresponding mean cognitive subscale scores for the Non-Pain, Orofacial Pain
and Fibromyalgia groups. For both Anxiety and Depression, there was a bigger difference
between the mean somatic and cognitive sub-scale scores in the Fibromyalgia group than in the
Non-Pain group. The somatic-cognitive subscale score differences for the Orofacial Pain group
did not differ from the Non-Pain group regarding Anxiety and was not different from the NonPain and Fibromyalgia groups regarding Depression.
Subdivision of the Orofacial Pain group
For further analyses, the Orofacial Pain group was divided into three main subgroups:
Intracapsular, Neuropathic and Muscle disorders. The Neuropathic group could potentially be
further subdivided into “Episodic Neuropathic Pain” and “Continuous Neuropathic Pain”. The
muscle pain group could additionally be subdivided into “Local Muscle Pain” and “Central
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Muscle Pain” (see method section for description). A two-sample t-test was performed to
compare the outcome variables between the “Episodic” and “Continuous” Neuropathic Pain
groups and between the “Local” and “Central” Muscle Pain groups respectively, to find out if
these additional subdivisions were appropriate.
Comparison of subjects with Episodic Neuropathic Pain vs. subjects with Continuous
Neuropathic Pain
Of the 88 participants with Neuropathic Pain, 61 participants had Continuous and 27
participants had Episodic Neuropathic Pain. A two-sample t-test did not reveal any significant
difference for any of the main outcome variables or potential co-variables between the two
subdivisions of Neuropathic Pain (Table 7). Based on this result, the group “Neuropathic Pain”
was kept as one group for further presentations and analyses.
Comparison of “Local” Muscle diagnoses vs. “Central” Muscle diagnoses
Of the 95 participants with Muscle Pain, 46 participants had “Local” and 49 participants
had “Central” Muscle Pain. A two-sample t-test did not reveal any significant difference for any
of the main outcome variables between the two subdivisions of Muscle Pain (Table 8). It did
though, show a higher VASAVE pain intensity level for the “Central” group compared to the
“Local” group (t(90) = -2.12 / p < 0.036). As the pain intensity level potentially could be a covariant for the outcome variables, it was decided to keep the subdivision of the Muscle group for
further analyses and presentations.
Analyses involving the Intracapsular Pain group, Neuropathic Pain group, Local Muscle
Pain group, Central Muscle Pain group and Fibromyalgia group
Mean Somatization, Anxiety and Depression scores
The mean scores and accompanying standard deviations for the SCL-90-R Somatization,
Anxiety and Depression scales are presented in Table 9.

28

Analyses of variance revealed a significant group effect for Somatization (F(4,310) =
22.94 / p < 0.001), Anxiety (F(4,310) = 10.50 / p < 0.001) and Depression (F(4,310) = 11.16 / p
< 0.001). Post hoc tests for mean Somatization scores revealed no significant differences within
the following clusters of groups: Intracapsular and Local Muscle; Neuropathic and Local
Muscle; Neuropathic and Central Muscle; Central Muscle and Fibromyalgia. Post hoc tests for
mean Anxiety and Depression scores revealed no significant differences within the following
clusters of groups: Intracapsular; Neuropathic, Local Muscle, Central Muscle and Fibromyalgia.
Cognitive-somatic patterning for the Anxiety and Depression scales
Analyses of variance revealed a significant group effect for the numeric differences in
subscale scores for the Anxiety scale (F(4,310) = 7.22 / p < 0.001) and for the Depression scale
(F(4,310) = 3.45 / p < 0.009). Post hoc tests for the mean subscale differences for the Anxiety
scale (CASA) revealed no significant differences within the following clusters of groups:
Intracapsular and Local Muscle; Neuropathic, Local Muscle and Central Muscle; Neuropathic,
Central Muscle and Fibromyalgia. Post hoc tests for the mean subscale differences for the
Depression scale (CDSD) revealed no significant differences within the following clusters of
groups: Intracapsular, Neuropathic, Local Muscle and Central Muscle; Intracapsular,
Neuropathic, Central Muscle and Fibromyalgia.
Summary
The mean Somatization scores were higher for the Central Muscle and the Fibromyalgia
groups than for the Local Muscle and Intracapsular groups. The mean Somatization score for the
Neuropathic Pain group did not differ from the Local and the Central Muscle group scores. The
mean Anxiety and Depression scores were higher for the Neuropathic, Local Muscle, Central
Muscle and Fibromyalgia groups than for the Intracapsular group.
The mean somatic subscale scores for Anxiety and Depression were higher than the mean
cognitive subscale scores for the Intracapsular, Neuropathic, Local Muscle, Central Muscle and
Fibromyalgia groups. For Anxiety, there was a bigger difference between the mean somatic and
the mean cognitive subscale scores in the Fibromyalgia group than in the Intracapsular and Local
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Muscle group. The mean cognitive-somatic subscale score differences for the Neuropathic, Local
Muscle and Central Muscle groups did not differ among each other. For Depression, there was a
bigger difference between the mean somatic and the mean cognitive subscale scores in the
Fibromyalgia group than in the Local Muscle group. The mean cognitive-somatic subscale score
differences for the Intracapsular, Neuropathic and Central Muscle groups did not differ among
each other or from any of the other groups.
Analyses involving the Intracapsular Pain group, Neuropathic Pain group, Local Muscle
Pain group and Central Muscle Pain group
Due to the introduction of average pain level as an additional co-factor in the following
analyses, the number of data responses vary from the analyses in the previous chapter. The
descriptive statistics are therefore presented again as they also differ slightly from the previous
chapter.
Mean Somatization, Anxiety and Depression scores
The mean scores and accompanying standard deviations for the SCL-90-R Somatization,
Anxiety and Depression scales are presented in Table 10.
Analyses of variance revealed a significant group effect for Somatization (F(3,230) =
4.50 / p < 0.004), Anxiety (F(3,230) = 6.75 / p < 0.001) and Depression (F(3,230) = 5.37 / p <
0.001). Post hoc tests for mean Somatization scores revealed no significant differences within the
following clusters of groups: Intracapsular, Neuropathic and Local Muscle; Neuropathic, Local
Muscle and Central Muscle. Post hoc tests for mean Anxiety and Depression scores revealed no
significant differences within the following clusters of groups: Intracapsular and Neuropathic;
Neuropathic, Local Muscle and Central Muscle.
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Cognitive-somatic patterning for the Anxiety and Depression scales
Analyses of variance revealed non-significant group effects for the numeric differences in
subscale scores for the Anxiety scale (F(3,230) = 1.91 / p < 0.128) and for the Depression scale
(F(3,230) = 2.02 / p < 0.111).
Summary
The mean Somatization scores were higher for the Central Muscle group than for the
Intracapsular group. The mean Somatization scores for the Neuropathic and Local Muscle
groups were not different from any of the groups. The mean Anxiety and Depression scores were
higher for the Local and Central Muscle groups than for the Intracapsular group. The mean
Anxiety and Depression scores for the Neuropathic group were not different from any of the
groups.
The somatic-cognitive subscale score differences for Anxiety and Depression did not
differ among any of the groups.
Analyses involving the MPI Profile groups: Adaptive Coper, Dysfunctional and
Interpersonally Distressed (Based on the Orofacial Pain subgroups)
Mean ages for the MPI profile groups are presented in Table 11. Analyses of variance
revealed no significant group effect for these mean ages (F(2,131) = 0.295 / p < 0.745).
Mean Somatization, Anxiety and Depression scores
The lowest mean values for the SCL-90-R Somatization, Anxiety and Depression scores
were found in the Adaptive Coper group and the highest values in the Dysfunctional group
(Table 11).
Analyses of variance revealed a significant group effect for Somatization (F(2,129) =
13.66 / p < 0.001), Anxiety (F(2,129) = 8.34 / p < 0.001) and Depression (F(2,129) = 13.40 / p <
0.001). Post hoc tests for mean Somatization scores revealed no significant differences within the
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following clusters of groups: Adaptive Copers; Interpersonally Distressed and Dysfunctional.
Post hoc tests for mean Anxiety and Depression scores revealed no significant differences within
the following clusters of groups: Adaptive Copers and Interpersonally Distressed; Interpersonally
Distressed and Dysfunctional.
Cognitive-somatic patterning for the Anxiety and Depression scales
The mean somatic subscore was higher than the mean cognitive subscore for both the
Anxiety and Depression scales in all MPI profile-groups (Table 12). A paired t-test for intragroup comparisons of the somatic and the cognitive subscale scores yielded significant
differences of all the corresponding subscores for both scales in all groups (Table 12).
Analyses of variance revealed non-significant group effects for the numeric differences in
subscale scores for the Anxiety scale (F(2,129) = 1.31 / p < 0.275) and for the Depression scale
(F(2,129) = 0.73 / p < 0.486).
Summary
There were no differences in mean age between the MPI profile groups. The mean
Somatization scores were higher for the Interpersonally Distressed and Dysfunctional groups
than for the Adaptive Copers. The mean Anxiety and Depression scores were higher for the
Dysfunctional group than for the Adaptive Copers. The Interpersonally Distressed group did not
differ from any of the other groups. The Anxiety and Depression subscale score differences were
not different among the MPI profile groups.
Comparison of the subsets COG and SOM
Based on the Orofacial Pain subgroups, the following subsets were compared:
COG: Participants having a higher cognitive than somatic subscale score on the Anxiety and/or
the Depression subscales.
SOM: Participants having a higher somatic than cognitive subscale score on the Anxiety and/or
the Depression subscales.
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MPI Profile distribution
The two subsets did not reveal any difference in MPI Profile distribution (Table 13). Chi
Square value for Table 13 was 6.48 (df 5) / p < 0.263.
Mean SCL-90-R scale scores
Independent sample t-tests revealed significantly higher scores for COG than SOM for
the following variables: SCL Anxiety, SCL Depression, SCL Obsessive Compulsiveness, SCL
Interpersonal Sensitivity, SCL Hostility, SCL Phobic Anxiety, SCL Paranoid Ideation and SCL
Psychotisism. There were no evidence of differences between COG and SOM for Somatization,
VASAVE, DURATION and age. See Table 14 for mean values and statistics.
Summary
The COG group revealed higher endorsement on all SCL-90-R scales except for
Somatization. There were no differences between COG and SOM for Somatization, average pain
intensity level, duration of pain, age and MPI profile distribution.
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Summary of results
The mean Somatization, Anxiety and Depression scores were significantly different
across the different groups with the Non-Pain group having the lowest scores and the
Fibromyalgia group having the highest scores. The Orofacial Pain group scores were between the
Non-pain and the Fibromyalgia groups. The mean Somatization, Anxiety and Depression scores
were higher for the Central Muscle and Fibromyalgia groups than for the Intracapsular group.
In general, the mean somatic subscale scores for Anxiety and Depression were higher
than the corresponding mean cognitive subscale scores. The mean Anxiety and Depression
cognitive-somatic subscale score differences however, were greater in the Fibromyalgia group
than in the Non-Pain group. When comparing the different Orofacial Pain subgroups and the
Fibromyalgia group, the mean Anxiety and Depression cognitive-somatic subscale score
differences were greater in the Fibromyalgia group than in the Local Muscle Pain group. No
differences in the mean Anxiety and Depression subscale score differences could be shown
among the Orofacial Pain groups.
For the Orofacial Pain participants, the mean Somatization, Anxiety and Depression
scores were higher in the MPI Dysfunctional Profile group than in the MPI Adaptive Coper
Profile group. Somatization scores for the Interpersonally Distressed Profile group were not
different from scores obtained from the Dysfunctional Profile group. Anxiety and Depression
scores for the Interpersonally Distressed Profile group were not different from scores obtained
from the Adaptive Coper group and from those with a Dysfunctional profile. The mean ages as
well as the mean Anxiety and Depression cognitive-somatic subscale score differences were not
different among the MPI Profile groups.
For the Orofacial Pain group, the subset of participants having a higher cognitive than
somatic subscale score on the Anxiety and/or Depression scales, compared to those participants
who endorsed somatic items more than cognitive ones on the same scales, demonstrated higher
mean scores for the following SCL-90-R scales: Obsessive-Compulsiveness, Interpersonal
Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychotisism.
Mean Somatization score, pain intensity level, duration of pain, age and MPI profile distribution
were not different between these two subsets of participants.
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t-value
-6.86
-4.09
-7.39
-7.09
-9.72
-7.92
-4.58
-2.00
-4.91
-4.56
-9.18
-6.74

df
51
51
121
116
77
77
41
40
48
43
49
49

Mean SCL-90-R Somatization, Anxiety and Depression raw-scores for the Non-Pain,

Std. dev.
0.34
0.37
0.48
0.52
0.53
0.71
0.53
0.90
0.76
0.72
0.60
0.72

p<
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.01
0.01
0.01
0.01

Somatization
Anxiety
Depression
Mean score Std. deviation Mean score Std. deviation Mean score Std. deviation
0.37
0.38
0.25
0.32
0.40
0.46
0.73
0.66
0.51
0.64
0.74
0.75
1.46
0.76
0.72
0.56
1.18
0.75

Orofacial Pain and the Fibromyalgia groups.

Non-Pain
Orofacial Pain
Fibromyalgia

Table 6:

Fibromyalgia

Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)

cog-som
-0.23
-0.15
-0.32
-0.34
-0.58
-0.64
-0.38
-0.28
-0.53
-0.50
-0.78
-0.69

Local Muscle, Central Muscle and Fibromyalgia groups.

and paired t-test comparing the cognitive and somatic subscale scores for the Non-Pain, Intracapsular, Neuropathic,

Mean cognitive and somatic subscale score differences for SCL-90-R Anxiety (CASA) and Depression (CDSD)

Central Muscle

Local Muscle

Neuropathic

Intracapsular

Non-Pain

Table 5:
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CDSD

CASA

Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain
Continuous NP Pain
Episodic NP Pain

Mean
48.16
53.96
59.88
58.12
40.13
43.40
0.96
0.90
0.70
0.58
0.95
0.87
0.64
0.48
0.66
0.58

Std. dev.
11.40
15.57
24.63
28.18
50.25
82.68
0.71
0.77
0.68
0.57
0.65
0.72
0.54
0.52
0.64
0.88
83
83
83

0.38
0.78
0.48

0.48

76

76

83

-0.22

1.27

82

38.85

df

0.29

-1.74

t-value

0.64

0.21

0.63

0.44

0.71

0.82

0.77

0.09

p<

Mean values and statistics for the comparison between participants with Continuous and Episodic Neuropathic Pain.

Average pain intensity level
(100 mm VAS scale)
Duration of pain
(months)
SCL-90-R Somatization
raw-score
SCL-90-R Anxiety
raw-score
SCL-90-R Depression
raw-score

Age (years)

Table 7:
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CDSD

CASA

Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain
Local Muscle Pain
Central Muscle Pain

Mean
38.52
36.14
45.34
56.46
41.75
39.36
0.88
1.14
0.77
0.80
1.07
1.03
0.38
0.53
0.28
0.50

Std. dev.
14.02
12.77
25.12
25.07
67.96
63.31
0.80
0.88
0.77
0.90
1.00
0.87
0.53
0.76
0.90
0.72
93
93
93

-1.45
-0.21
0.21

-1.22

83

85.65

83

0.17

-1.16

90

93

df

-2.12

0.87

t-value

0.23

0.25

0.84

0.83

0.15

0.87

0.04

0.39

p<

Mean values and statistics for the comparison between participants with Central Muscle and Local Muscle Pain.

Average pain intensity level
(100 mm VAS scale)
Duration of pain
(months)
SCL-90-R Somatization
raw-score
SCL-90-R Anxiety
raw-score
SCL-90-R Depression
raw-score

Age (years)

Table 8:
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Somatization
Mean score Std. deviation
0.47
0.44
0.85
0.65
0.74
0.68
1.10
0.86

Anxiety
Mean score Std. deviation
0.26
0.37
0.58
0.59
0.68
0.73
0.79
0.82

Depression
Mean Score Std. deviation
0.46
0.56
0.89
0.70
0.99
1.04
0.99
0.82

Mean SCL-90-R Somatization, Anxiety and Depression raw-scores for the Orofacial Pain subgroups.

Intracapsular
Neuropathic
Local Muscle
Central Muscle

Table 10:

Somatization
Anxiety
Depression
Mean score Std. deviation Mean score Std. deviation Mean Score Std. deviation
0.49
0.44
0.27
0.39
0.46
0.57
0.87
0.67
0.60
0.61
0.89
0.69
0.75
0.66
0.66
0.70
0.97
0.99
1.15
0.87
0.83
0.90
1.04
0.84
1.46
0.76
0.72
0.56
1.18
0.75

the Fibromyalgia group.

Mean SCL-90-R Somatization, Anxiety and Depression raw-scores for the Orofacial Pain subgroups and

Intracapsular
Neuropathic
Local Muscle
Central Muscle
Fibromyalgia

Table 9:
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DYSF

IPD

ADAPT

Table 12:

ADAPT
IPD
DYSF

Table 11:

Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)
Anxiety (CASA)
Depression (CDSD)

cog-som
-0.47
-0.60
-0.70
-0.72
-0.71
-0.59

Std. dev.
0.53
0.63
0.66
0.59
0.68
0.93

t-value
-7.33
-7.78
-5.01
-5.64
-6.13
-3.79

Interpersonally Distressed (IPD) and Dysfunctional (DYSF) groups.
df
67.00
67.00
21.00
20.00
33.00
35.00

p<
0.01
0.01
0.01
0.01
0.01
0.01

and paired t-test comparing the cognitive and somatic subscale scores for the MPI Adaptive Coper (ADAPT),

Mean cognitive and somatic subscale score differences for the SCL-90-R Anxiety (CASA) and Depression (CDSD)

Somatization
Age
Anxiety
Depression
Mean (years) Std. deviation Mean score Std. deviation Mean score Std. deviation Mean Score Std. deviation
0.71
0.50
0.49
0.47
0.70
0.57
42.06
14.22
1.19
0.80
0.81
0.73
1.00
0.64
44.48
14.32
1.39
0.87
1.06
0.99
1.44
0.94
43.16
14.53

Adaptive Copers (ADAPT), Interpersonally Distressed (IPD) and Dysfunctional (DYSF).

Mean ages and mean SCL-90-R Somatization, Anxiety and Depression raw-scores for the MPI Profile groups:
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MPI Profile distribution for the COG and SOM subsets.

MPI Profile groups
Interpersonally Adaptive
Coper
Hybrid
Dysfunctional Distressed
Count
13
2
14
4
COG
% within group
20.0%
3.1%
21.5%
6.2%
Group
Count
39
25
76
8
SOM
% within group
12.6%
8.1%
24.6%
2.6%
Count
52
27
90
12
Total
% within group
13.9%
7.2%
24.1%
3.2%

Table 13:

Anomalous Uniterpretable
19
13
29.2%
20.0%
100
61
32.4%
19.7%
119
74
31.8%
19.8%

65
100%
309
100%
374
100%

Total
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COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM
COG
SOM

Mean
38.91
42.07
42.06
46.94
35.81
38.65
0.80
0.74
1.10
0.68
0.84
0.37
1.27
0.62
0.88
0.44
0.73
0.39
0.41
0.15
0.59
0.28
0.50
0.18

Std. dev.
15.70
15.54
29.41
28.87
66.58
71.89
0.72
0.70
0.88
0.73
0.87
0.48
1.05
0.64
0.90
0.53
0.80
0.51
0.76
0.40
0.76
0.52
0.69
0.34
357
353
373
373
75.05
77.11
76.36
77.75
74.14
79.91
73.32

-0.29
0.71
4.09
4.32
4.89
3.90
3.31
2.74
3.23
3.75

386

df

-0.47

-1.51

t-value

Mean values and statistics for the comparison between the COG and SOM subsets.

Average pain intensity level
(100 mm VAS scale)
Duration of pain
(months)
SCL-90-R Somatization
raw-score
SCL-90-R Obsessive-Compulsive
raw-score
SCL-90-R Interpersonal Sensitivity
raw-score
SCL-90-R Depression
raw-score
SCL-90-R Anxiety
raw-score
SCL-90-R Hostility
raw-score
SCL-90-R Phobic Anxiety
raw-score
SCL-90-R Paranoid Ideation
raw-score
SCL-90-R Psychoticism
raw-score

Age (years)

Table 14:

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.48

0.78

0.64

0.13

p<

Chapter Four
Discussion
In agreement with the hypotheses, the Somatization and Anxiety scores were higher for
the Orofacial Pain and Fibromyalgia groups than for the Non-Pain group. As predicted, this was
true for the Depression scores also. When contrasting the Orofacial Pain subgroups, the Central
Muscle group revealed higher Somatization, Anxiety and Depression scores than the
Intracapsular group. This partly confirmed the hypotheses, as the expected higher scores for the
Neuropathic and Local muscle groups than the Intracapsular group could not be confirmed. The
Fibromyalgia group revealed higher Somatization, Anxiety and Depression scores than the
Intracapsular group.
The mean somatic subscale scores for Anxiety and Depression were higher than the
corresponding cognitive scores for all groups and subgroups. This was partly in agreement with
the hypothesis, as the Non-Pain group was originally expected to reveal equal somatic and
cognitive subscale scores. The hypothesized differential values for the Anxiety and Depression
subscale score differences among the Orofacial Pain subgroups could not be confirmed. When
introducing the Fibromyalgia and Non-Pain groups in the comparisons, the Fibromyalgia group
demonstrated higher Anxiety and Depression subscale score differences than the Local Muscle
and Non-Pain groups respectively, which only partly confirmed the original hypotheses.
The MPI Dysfunctional group revealed higher mean Somatization, Anxiety and
Depression scores than the MPI Adaptive Coper group. This partly confirmed the hypotheses,
which additionally had predicted dissimilarity between the MPI Adaptive Coper and
Interpersonally Distressed groups. As the Dysfunctional group per definition reveal more
psychological distress and a higher pain intensity level than the Adaptive Coper group, these
findings were not surprising. As an adjustment was made for the average pain intensity level, the
higher Somatization score for the Dysfunctional group than the Adaptive Coper group must be
related to other physical complaints than the pain intensity. The hypothesized differential values
for Anxiety and Depression cognitive-somatic subscale score differences could not be confirmed
for the MPI Profile groups. This shows that no differentiated relationship between physical
complaints and cognitive aspects of psychological distress exists among the different
dysfunctional groups.
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The subset of Orofacial Pain participants revealing a higher cognitive than somatic score
on the Anxiety and/or Depression scales revealed a higher level of psychopathology expressed
through higher scores on all SCL-90-R scales, except Somatization. These findings were the
opposite of what was hypothesized. The findings could suggest that somatic subscale
endorsement might be less related to development of psychopathology than cognitive subscale
endorsement is. The fact that the mean somatic Anxiety and Depression subscale scores were
higher than the mean cognitive subscale scores in all groups may suggest that somatic complaints
are common also in a non-pain population, but that these complaints do not necessarily involve
painful symptoms.
Consistent with the findings of Buckelew et al. (1986), the pain participants revealed
higher Somatization scores than the Non-Pain participants. This would be expected due to
more/stronger bodily symptoms in the Pain groups than in the Non-Pain group. These findings
are also in agreement with McCracken’s finding of frequent somatic symptoms in a chronic pain
population (1998). The higher endorsement of somatic than cognitive items on the Anxiety and
Depression scales, which was reported for the pain group in the studies of Buckelew et al. (1986)
and DeGood et al. (1985) was not found in the present study. Buckelew’s and DeGood’s mean
scores were not adjusted for pain intensity or pain duration, and the somatic-cognitive patterning
in that material was therefore probably dependent on one or both of these factors and not on
group characteristics.
The finding that the subset of patients revealing higher Anxiety and/or Depression
cognitive subscale scores than somatic subscale scores revealed higher scores on all SCL-90-R
scales (except Somatization) while their pain intensity levels were the same, was directly
opposite of the results reported by Buckelew et al.. Buckelew et al. felt that the analog subset
from their own study represented more psychologically minded patients that already had sought
treatment for mental health problems. Lower SCL-90-R scores for these subjects would therefore
be expected. The findings from the present study may suggest that a high cognitive endorsement
on the Anxiety and/or Depression scales does not express cognitive coping, but rather
dysfunctional cognitive processes (e.g. catastrophizing).
In the present study, the creation of the COG and SOM subsets was based on both the
Anxiety and the Depression scales for all Orofacial Pain participants from all Orofacial Pain
diagnostic subgroups, but not containing clinical data. It was therefore not possible to evaluate if
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either of the subsets (COG or SOM) would be derived from a specific scale (Anxiety or
Depression). Further, it could not be evaluated if either of the subsets would be associated with
specific total SCL-90-R Anxiety and/or Depression score levels or associated with specific
diagnostic subgroups and/or clinical parameters.
Weinberger et al stated (1979) that patients with repressive coping styles create a special
clinical problem as they seem to be resistant to psychological interventions and seem to be
highly prone to develop somatic complaints. Buckelew et al. drew similarities between
repressors as described by Weinberger and chronic pain patients from their own study. Based on
the present data, an analysis of cognitive-somatic item response patterning does not seem useful
for “diagnosing” pain patients as about 80% of all pain patients in this study and also in
Buckelew’s material revealed higher somatic than cognitive subscale scores.
Wilson et al. (1994) reported that high Somatization scores and high pain intensity scores
were predictors of widespread muscle pain on palpation. A detailed comparison between
Wilson’s study and the present study must be done with caution, as different methodologies were
applied. Wilson et al. contrasted the non-somatic items on the SCL-90-R Anxiety and
Depression scales with the SCL-90-R Somatization scale score. The present study also used the
non-somatic items on the SCL-90-R Anxiety and Depression scales, but instead of the SCL-90-R
Somatization score, the somatic items from the SCL-90-R Anxiety and Depression scales were
used. Wilson et al. recorded pain on palpation while the present study used pain report by
history. In the present study, the Central Muscle Group revealed higher Somatization scores than
the Intracapsular group and the Pain groups demonstrated higher Somatization scores than the
Non-Pain group. These findings could be interpreted as similar to the results of Wilson et al. If
the higher Somatization scores for the Pain participants than the Non-Pain participants were
based on group specific characteristics, on the extent of potential central involvement or on pain
intensity level could not be decided, as the mean values in this comparison were not adjusted for
the pain intensity level. This adjustment could however be performed for the mean values in the
comparison of the Orofacial Pain subgroups.
Although muscle pain is classified as somatic pain in contrast to neuropathic pain and
these two entities often are thought to underlie different pathophysiological mechanisms, it is
still difficult to explain why only the Central Muscle Pain group and not the Neuropathic Pain
group would reveal higher Somatization scores than the Intracapsular group, as both chronic
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Central Muscle and Neuropathic pain would be considered conditions of central nervous system
involvement. Until further and repeated data can support such a difference between the Central
Muscle Pain and Neuropathic Pain groups, the present difference between these two groups must
be regarded as to have occurred by chance and not to represent neurobiological differences
between the groups. Wilson et al. also demonstrated that cognitive symptoms of psychological
distress were less likely to be related to report of clinically widespread pain, but this could not be
confirmed by the present study, as no group differences were detected for the Anxiety and
Depression cognitive-somatic patterning.
Bridges (1991) compared primary care patients with somatic symptoms of distress and
patients presenting with psychological symptoms. His findings suggested that “somatizers” were
less depressed and less socially distressed than “psychologizers” were. While it is not known
what pain-symptoms were in Bridges’ material, one could consider the SOM group from the
present study as “somatizers” and the COG group as “psychologizers”. The finding that the COG
group revealed more psychopathology than the SOM group would then resemble the findings of
Bridges and suggest that most pain patients develop mainly somatic symptoms, but a subset of
pain patients also reveal predominant psychopathology. It is not possible to evaluate if this
psychopathology is secondary to pain and suffering or preceding / partially contributing to the
pain condition.
There were several limitations of this study. As the average pain intensity scores were not
available for the Fibromyalgia group, the mean scores could not be adjusted accordingly and
limited conclusions could be drawn concerning potential differences between the Orofacial Pain
and the Fibromyalgia group. In comparison of the Non-pain, Orofacial Pain and Fibromyalgia
groups, as the mean values were only corrected for age, the higher Somatization, Anxiety and
Depression scores, which were found for the Fibromyalgia group compared to the Orofacial Pain
group must be interpreted with care, as the results could be confounded by other factors, e.g. pain
intensity level and/or duration of pain. Further, the higher cognitive than somatic Anxiety and
Depression subscale scores for the Fibromyalgia group than the Local Muscle and Non-Pain
groups must also be interpreted with caution. The higher subscale score differences for the
Fibromyalgia group could have resulted from differences in average pain intensity between the
groups as in this comparison no correction was made for this factor.
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The orofacial pain data were extracted from a database of over 2000 patients from a
tertiary treatment center. Different patients saw different health professionals who may use
different approaches in their diagnostic work up and also may have different priorities for their
diagnostic listing of complaints. The data have been collected over many years with the
possibility of change in diagnostic concepts over time. Although these factors are potential error
sources, due to the size of the database and a fairly constant basic diagnostic strategy within the
Orofacial Pain Center over time, it is felt that no segregation of errors within specific subgroups
was likely to have significantly influenced patient classification.
The different subscales that were constructed to capture the differentiated cognitivesomatic item endorsements were based on the SCL-90-R Anxiety and Depression scales. These
subscales were first introduced for this purpose and published by Buckelew et al. in 1986. It is
important to remember that although these subscales also in the present study revealed
satisfactory internal consistency reliability, the subscales have not been widely used and validity
data have not been established. It is also important to keep in mind that psychometric evaluation
of patients involves more than only the selected scales used in this study. On an individual basis
it would be necessary to take data from the complete SCL-90-R into consideration.
Future research should include data containing information of pain intensity for
fibromyalgia patients. In this way a comparison of SCL-90-R Somatization, Anxiety and
Depression scores between the Orofacial Pain and the Fibromyalgia groups could be performed
with mean values also adjusted for pain intensity. Then the role of pain intensity as a potential
confounding factor could be established. Further, a regression analysis would reveal the relative
contribution of the different co-factors for the SCL-90-R scale and subscale scores.
The present findings for the COG and SOM subsets suggest more detailed studies,
especially concerning the relationship between the characteristics of the COG subset and type of
psychological distress, e.g. if the expressed psychopathology is pain related or not. Further,
longitudinal studies on the chronological development of dysphoria in the COG subset would be
necessary to find out if the dysphoria precedes or follows the pain condition. It would also be
interesting to find out how the COG and SOM subsets relate to the different diagnostic
subgroups. Schwartz (1978) suggested that anxiety would be made up of patterns of specific
psychobiological processes. Future research into the COG and SOM subsets may reveal
interesting information about such patterns or about further subdivisions of the pain groups. Such
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information could also give insight into potential predictive properties of the cognitive-somatic
patterning.
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Conclusion
Based on the results of this study, adding an analysis of somatic-cognitive item response
patterning in the diagnostic work-up of chronic pain patients would not provide clinically useful
information. Until data from prospective and retrospective longitudinal studies can substantiate
the value for such an analysis for diagnostic purposes and its predictive utility for the
development of pain chronicity, the differentiation of cognitive-somatic patterns remains an
interesting heuristic exercise but does not contribute to developing a broader understanding of
those factors that are associated with positive or negative clinical presentations.
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Appendices
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Appendix A: Patient information letter and questionnaires
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1. Patient information letter
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2. Demographic questionnaire (Non-Pain group)
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3. SCL-90-R, page 1
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4. SCL-90-R, page 2
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Appendix B: Scales / Subscales
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SCL-90-R scales utilized in this study
Somatization (12 items)___________________________________________________
Headaches
Faintness or dizziness
Pains in heart or chest
Pains in lower back
Nausea or upset stomach
Soreness of your muscles
Trouble getting your breath
Hot or cold spells
Numbness or tingling in parts of your body
A lump in your throat
Feeling weak in parts of your body
Heavy feelings in your arms or legs
Depression (13 items)_____________________________________________________
Loss of sexual interest or pleasure
Feeling low in energy or slowed down
Thoughts of ending your life
Crying easily
Feeling of being caught or trapped
Blaming yourself for things
Feeling lonely
Feeling blue
Worrying too much about things
Feeling no interest in things
Feeling hopeless about the future
Feeling everything is an effort
Feelings of worthlessness
Anxiety (10 items)________________________________________________________
Nervousness or shakiness inside
Trembling
Suddenly scared for no reason
Feeling fearful
Heart pounding or racing
Feeling tense or keyed up
Spells of terror or panic
Feeling so restless you couldn’t sit still
The feeling that something bad is going to happen to you
Thoughts and images of a frightening nature
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Subscales of Anxiety and Depression.

Cognitive Anxiety (5 items)________________________________________________
Suddenly scared for no reason
Feeling fearful
Spells of terror or panic
The feeling that something bad is going to happen to you
Thoughts and images of a frightening nature
Somatic Anxiety (5 items)__________________________________________________
Nervousness or shakiness inside
Trembling
Heart pounding or racing
Feeling tense or keyed up
Feeling so restless you could not sit still
Cognitive Depression (13 items)____________________________________________
Thoughts of ending your life
Crying spells
Feelings of being caught or trapped
Blaming yourself for things
Feeling lonely
Feeling blue
Worrying too much about things
Feeling no interest in things
Feeling hopeless about the future
Feeling everything is an effort
Feeling of worthlessness
Thoughts of death or dying
Feelings of guilt
Somatic Depression (7 items)_______________________________________________
Loss of sexual interest or pleasure
Feeling low in energy or slowed down
Poor appetite
Overeating
Trouble falling asleep
Awakening in the early morning
Sleep that is restless or disturbed
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